Cytosorbents Corporation ( CTSO) - Key Metrics
CTSO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.15 | -$0.07 | -$0.03 | -$0.03 |
| 2026Q1 | $0.14 | -$0.08 | -$0.02 | -$0.02 |
| 2025Q4 | $0.15 | -$0.09 | -$0.08 | -$0.08 |
| 2025Q3 | $0.15 | -$0.05 | -$0.04 | -$0.04 |
| 2025Q2 | $0.15 | $0.03 | -$0.02 | -$0.02 |
CTSO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.34 |
| 2026Q1 | 0% | -1.77 |
| 2025Q4 | 0% | -1.83 |
| 2025Q3 | 0% | -4.67 |
| 2025Q2 | 0% | 10.29 |
CTSO
Price: $3.73
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.29 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 305200
Ebitda: -2.1 millionMarket Capitalization: 12.2 million